KINGWAI LUI: Open Payments
NPI 1639584220 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 19 payments from 9 companies in 2025. Trend: 2023 $411 · 2024 $238 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 2 | $148 |
| ABBVIE INC. | 3 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Alkermes, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, UZEDY, REXULTI, Qelbree, ARISTADA, ABILIFY MAINTENA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
